Sold as Chromic Chloride In Plastic Container, Chromic Chloride. Every FDA application for this active ingredient: 2 branded and 1 generic.
As of Nov 15, 2026, FDA lists 3 applications for Chromic Chloride (sold as Chromic Chloride In Plastic Container, Chromic Chloride), first approved Jun 26, 1986, with 0 new uses approved and 0 published complete response letters.
| Jun 26, 1986 | Chromic Chloride In Plastic ContainerNDA 18961 · New formulation or manufacturer | Hospira | 11 | Marketed |
| May 5, 1987 | Chromic ChlorideNDA 19271 · New formulation or manufacturer | Abraxis Pharm | 3 | Discontinued |
| Nov 18, 2024 | Chromic ChlorideANDA 218538 | Somerset Theraps LLC | 0 | Marketed |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA
Abraxis Pharm